Can psychiatric medications really lead to dramatic weight gain? Does your socioeconomic status really determine if you’ll end up obese? And is there anything you can do about weight loss plateaus? Join us for an eye-opening episode of the Pound of Cure Weight Loss Podcast.

In today’s episode, we touch on a few key topics related to weight gain and weight loss challenges. First off, we dive into the role of medications that can actually cause weight gain. Things like antidepressants, mood stabilizers, and even birth control can seriously impact your body’s ability to maintain or lose weight. It’s not uncommon for people to be doing everything right with their diet and exercise, but these medications still push their weight up.

We also talk about frustrating weight loss plateaus. Everyone hits them at some point, and the key is not to freak out. Reverting back to only drinking protein shakes, is not going to solve the problem. Small changes—like adjusting your veggie intake or swapping out processed foods for whole foods—can make a big difference. And remember, plateaus are totally normal, so don’t feel like you're failing.

Finally, we touch on how socioeconomic status plays a major role in weight gain. People from lower-income backgrounds often have a harder time losing weight, partly because of limited access to healthier foods. Living in areas where fresh produce is hard to come by (hello, food deserts!) makes sticking to a healthy lifestyle that much tougher.

So, it’s a mix of factors outside your control like medications, hitting plateaus, and even where you live that can affect your weight loss journey.

In this episode, we unpack some fascinating insights from an NBC News article that highlights why most people stop using Wegovy after two years. Dr. Weiner shares his thoughts, explaining that a lack of access due to shortages, high costs, and insurance coverage issues are significant reasons why people discontinue these medications. The Pharmacy Benefit Managers (PBMs) who released the data might also have an agenda since they are not keen on covering expensive weight loss medications. Dr. Weiner believes that many people would continue using Wegovy if they had consistent access without these barriers.

We also hear Martin's inspiring weight loss journey. Initially struggling with his weight from a young age, he tried every fad diet before opting for weight loss surgery. Martin shares his experience with the lap band surgery in 2009, which didn’t work out as planned. He eventually transitioned to a gastric bypass after his wake-up call, realizing that he wanted to lead a healthier life for his family. Through a combination of gastric bypass, GLP-1 medications like Mounjaro, and the 10-to-1 protein rule, Martin achieved a significant weight loss. His story underlines the importance of finding a personal "why" and using it as motivation to make lasting lifestyle changes​​.

Dr. Weiner discusses the heritability of weight loss response to gastric bypass surgery, emphasizing that genetic factors often play a significant role in the success of such procedures. He cites a study showing that the genetic relationship between first-degree relatives had a more substantial impact on weight loss success after surgery than merely living together. This highlights the potential genetic influence on how individuals respond to both surgery and weight loss medications​.

We also dive into practical advice on reaching protein goals post-surgery. For those struggling with limited food volume, we recommend strategies like fortifying meals with protein powders and choosing nutrient-dense options like Greek yogurt or smoothies to meet protein targets without consuming large quantities of food. Achieving these protein goals can help speed up weight loss and break through plateaus​​.

Overall, this episode covers the complexities of weight loss, from understanding the barriers to medication adherence to navigating genetic influences and personalizing nutrition strategies.

In this episode, we tackle some hot topics and share inspiring stories. We start with a big piece of news: the CEO of Novo Nordisk being brought before a Senate committee. This is huge because Novo Nordisk is a major player in the GLP-1 medication world, and there's a lot of scrutiny on how these drugs are priced and covered by insurance.

We also dive into the incredible story of Leslie, who needed a combination of nutrition, exercise, GLP-1 medications, and bariatric surgery to lose an astonishing 157 pounds. Her journey is a powerful reminder that weight loss isn't a one-size-fits-all solution and often requires a multifaceted approach.

On a different note, we discuss some eye-opening research showing that obese people tend to earn less money than their non-obese counterparts. This wage gap is especially pronounced as education levels increase, which is both shocking and troubling.

We also get into the nitty-gritty of insurance coverage for GLP-1 medications. It's frustrating to see how many barriers there are for patients trying to get these potentially life-changing drugs. We offer some tips on how to navigate these challenges and advocate for better coverage.

Overall, this episode is packed with important information and real-life stories that highlight the complexities of weight loss and the broader societal issues related to obesity.